UBS raised the firm’s price target on Procter & Gamble to $170 from $161 and keeps a Buy rating on the shares. Procter & Gamble delivered a Q2 beat with fiscal 2026 guidance unchanged, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target raised to $165 from $158 at Wells Fargo
- Procter & Gamble upgraded to Overweight from Neutral at JPMorgan
- Procter & Gamble upgraded to Buy from Hold at DBS Bank
- Procter & Gamble Earnings Call: Growth Abroad, Strains at Home
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!